Ignite Creation Date:
2024-10-25 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06590506
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-26
Brief Title:
High Definition Medicine for Solid Tumors Oncology
Sponsor:
None
Organization:
None
Study Overview
Official Title:
High Definition Medicine Establishment of a Cohort of Patients With Advanced Cancer for Prospective High-resolution Follow-up
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HDM-PMP22
Brief Summary:
The present study aims to analyze different genetic phenotypic environmental social and lifestyle characteristics of cancer patients who are going to start a first line of cancer treatment with palliative intent and their possible relationship with tumor response or tolerance to treatment In this way the aim is to identify a series of variables that allow a better selection of patients and oncological treatments
Detailed Description:
The objective of this study is to obtain a cohort of patients with advanced cancer that is robust and large enough to study the nature and possible interrelation between these variables and their influence on the response and tolerance to treatment
To do this the investigators will rely on the first of the high-definition medicine strategies and evaluate the main health determinants of each individual
This strategy will be use because by obtaining a personal baseline from a sufficiently large cohort of patients the investigators will be able to interrelate and identify those variables that have greater weight when it comes to obtaining a response or good tolerance to oncological treatment
To do this the investigators will rely on the first of the high-definition medicine strategies and evaluate the main health determinants of each individual
This strategy will be use because by obtaining a personal baseline from a sufficiently large cohort of patients the investigators will be able to interrelate and identify those variables that have greater weight when it comes to obtaining a response or good tolerance to oncological treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None